Serhat SIĞIRCI, Ahmet GÜRDAL, Kadriye Orta KILIÇKESMEZ

Severity of coronary artery disease is associated with contrast induced nephropathy in patients with impaired renal function

Aim: Patients with acute coronary syndrome who underwent percutaneous coronary intervention (PCI) constitute the group with thehighest risk of contrast-induced nephropathy development. Contrast media exposure might increase in patients who have lesionswith >70% stenosis in the major epicardial arteries. Also, the impaired kidney function is associated with severity of coronary arterydisease. We evaluated the relationship with severity of coronary artery disease (CAD) calculated by Gensini score and contrastinduced nephropathy (CIN) in patients with mild renal insufficiency in acute coronary syndrome (ACS).Material and Methods: We enrolled 227 patients with ACS who underwent percutaneous coronary intervention. Patients weredivided into groups according to CIN development. Severity of CAD was evaluated by Gensini score. Logistic regression analysis(univariate and multivariate) was performed to evaluate the predictors of CIN using variables that are clinically related to CIN. The95% confidence interval (CI) and odds ratios (OR) were presented. Receiver–operating characteristic (ROC) curve was performed todemonstrate the sensitivity and specificity of the Gensini score.Results: A total of 69 (30.1%) patients with ACS had CIN. Compared to CIN (-) patients, CIN (+) patients had higher Gensiniscore, incidence of diabetes mellitus and amount of contrast media. Multivariate logistic regression analyses demonstrated thatGensini score, DM and amount of contrast media were independent risk factors for CIN development (p < 0.05 for all parameters).Conclusion: Gensini score, which simply shows severity of CAD, may be helpful in the determination of CIN risk in patients with ACS.

PDF

___

1. Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation. 2010;122:2451-5.
2. Sgura FA, Bertelli L, Monopoli D, at al. Mehran contrastinduced nephropathy risk score predicts short- and long-term clinical outcomes in patients with STelevation-myocardial infarction. Circ Cardiovasc Interv 2010;3:491-8.
3. Giacoppo D, Gargiulo G, Buccheri S, et al. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients. Circ Cardiovasc Interv 2017;10:e004383
4. Toprak O, Cirit M, Bayata S, at al. Review of the radiocontrast nephropathy risk profiles and risk stratification. Anatol J Cardiol. 2004;4:331-5.
5. Shacham Y, Steinvil A, Arbel Y. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity. J Nephrol 2016;29:169-74.
6. Bhatt H, Turkistani A, Sanghani D, at al. Do Cardiovascular Risk Factors and Coronary SYNTAX Score Predict Contrast Volume Use During Cardiac Catheterization? Angiology 2015;66:933-40.
7. Cay S, Metin F, Korkmaz S. Association of renal functional impairment and the severity of coronary artery disease. Anatol J Cardiol 2007;7:44-8
8. Gensini G. G. A more meaningful scoring system for determining the severity of coronary heart disease. American J Cardiology 1983;51:606.
9. Thygesen K, Alpert JS, Jaffe AS, at al. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019;40:237-69.
10. Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation. 2006;113:1799-806.
11. Rencuzogullari I, Çağdaş M, Karakoyun S, at al. Association of Syntax Score II with Contrast-induced Nephropathy and Hemodialysis Requirement in Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J 2018;48:59-70.
12. Wright RS, Reeder GS, Herzog CA, at al. Acute myocardial infarction and renal dysfunction: a highrisk combination. Ann Intern Med. 2002;137:563-70.
13. Marenzi G, Lauri G, Assanelli E, at al. Contrastinduced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004;44:1780-5.
14. Chaudhury P, Armanyous S, Harb SC, at al. IntraArterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis. Nephron 2019;141:31-40.
15. Sun G, Chen P, Wang K, at al. Contrast-Induced Nephropathy and Long-Term Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction. Angiology 2019;70:621- 6.
16. Uzunhasan I, Yildiz A, Arslan S, at al. ContrastInduced Acute Kidney Injury Is Associated With LongTerm Adverse Events in Patients With Acute Coronary syndrome. Angiology 2017;68:621-6.
17. Schönenberger E, Martus P, Bosserdt M, at al. Kidney Injury after Intravenous versus Intra-arterial Contrast Agent in Patients Suspected of Having Coronary Artery Disease: A Randomized Trial. Radiology 2019;292:664-72.
18. Caspi O, Habib M, Cohen Y, et al. Acute kidney injury after primary angioplasty: is contrast-induced nephropathy the culprit? J Am Heart Assoc 2017;6:e005715.
19. Lin KY, Shang XL, Guo YS, at al. Association of Preprocedural Hyperglycemia With Contrast-Induced Acute Kidney Injury and Poor Outcomes After Emergency Percutaneous Coronary Intervention Angiology 2018;69:770-8.
20. Sigirci S, Keskin K, Yildiz SS, at al. Can Thrombus Burden Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction? Angiology 2019;70:642-48.
21. Shacham Y, Steinvil A, Arbel Y. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity. J Nephrol 2016;29:169-74.
22. Kappetein AP, Dawkins KD, Mohr FW, at al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006;29:486-91.
23. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005;68:14-22.
24. Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. Annual Review of Immunology 2009;27:165-97.
25. Karabağ Y, Çağdaş M, Rencuzogullari I, at al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal 2018;32:e22457.
26. Aurelio A, Durante A. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment. Cardiology 2014;128:62-72.
27. Arvin P, Samimagham HR, Montazerghaem H, at al. Early detection of cardiac surgery‑associated acute kidney injury by microRNA-21. Bratisl Lek Listy 2017;118:626-31.
28. Abbas M, Jesel L, Auger C, at al. Endothelial Microparticles From Acute Coronary Syndrome Patients Induce Premature Coronary Artery Endothelial Cell Aging and Thrombogenicity: Role of the Ang II/ AT1 Receptor/NADPH Oxidase-Mediated Activation of MAPKs and PI3-Kinase Pathways. Circulation. 2017;135:280-96.
29. Huang PH, Chen JW, Lin SJ. Effects of Cardiovascular Risk Factors on Endothelial Progenitor Cell. Acta Cardiol Sin 2014;30:375-81.